Related Experiment Videos
Efficacy of ACTH 4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis
Insights
Methylphenidate significantly improved attention deficit disorder in Hong Kong children, enhancing vasomotor reactivity, behavior, and learning compared to ACTH 4-9 analog or placebo. Further research is suggested.
Area of Science:
- Neuroscience
- Pediatrics
- Psychopharmacology
Background:
- Attention deficit disorder (ADD) is a prevalent neurodevelopmental disorder in children.
- Current treatments for ADD include stimulant medications, but efficacy and side effects vary.
- Adrenocorticotropic hormone (ACTH) 4-9 analog is a potential therapeutic agent for cognitive disorders.
Purpose of the Study:
- To compare the efficacy of methylphenidate, ACTH 4-9 analog, and placebo in treating ADD in Hong Kong (HK) children.
- To evaluate the impact of these treatments on psychometric measurements, behavioral improvements, and learning receptivity.
Main Methods:
- A randomized controlled trial was conducted with 30 HK children diagnosed with ADD.
- Children were stratified into three groups based on body weight and received either placebo, methylphenidate, or ACTH 4-9 analog.
- Psychometric measurements, vasomotor reactivity, and behavioral observations were used to assess treatment outcomes.
Main Results:
- Children treated with methylphenidate demonstrated significantly greater improvements in vasomotor reactivity, behavioral responses, and learning receptivity.
- The ACTH 4-9 analog and placebo groups showed less pronounced improvements compared to the methylphenidate group.
- Methylphenidate proved more effective than ACTH 4-9 analog and placebo in managing ADD symptoms in this cohort.
Conclusions:
- Methylphenidate is a highly effective treatment for ADD in HK children, offering significant benefits over ACTH 4-9 analog and placebo.
- The findings support the use of methylphenidate for improving cognitive and behavioral outcomes in pediatric ADD.
- Further research is warranted to explore the long-term effects and potential of ACTH 4-9 analog in specific pediatric populations.
Abstract:
The present study compared the efficacy of ACTH 4-9 analog, methylphenidate, and placebo on attention deficit disorder with 30 (HK) children with attention deficit disorder and psychometric measurements. HK children were randomly placed into three groups, according to body weight, and treated with placebo, methylphenidate, and adrenocorticotropic hormone fractions (ACTH 4-9 analog). The results revealed that HK children on methylphenidate manifested a significantly greater vasomotor reactivity, behavioral improvement, and learning receptivity than HK children taking ACTH 4-9 analog and/or placebo. Future research implications with ACTH 4-9 and HK children are discussed.